EUVIMEDEUVIMED entdecken
Crossref

L26/O-275 Beyond euploidy: euploid frozen embryo transfer does not improve live birth rates in women with recurrent pregnancy loss

T. Blagojevic, H. Didar, B. Lawrenz, S. Selim, I. Elkhatib, H. Fatemi

Human Reproduction · 01.07.2026 · 41 (Supplement_1)

DOI: 10.1093/humrep/deag083.273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von T. Blagojevic und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Does euploid frozen embryo transfer improve live birth rates in women with a history of recurrent pregnancy loss (RPL)? Summary answer After euploid FET, patients with RPL—regardless of work-up findings—had significantly lower live birth rates than those without miscarriage history What is known already Recurrent pregnancy loss (RPL), characterized by two or more pregnancy losses before to 20 weeks of gestation, impacts 1–3% of couples and may result from anatomical anomalies, atypical parental chromosomes, antiphospholipid syndrome, and certain autoimmune diseases. With the current plattforms, up to 60% of RPL can be attributed to fetal aneuploidy; hence, IVF/ICSI-treatments, combined with embryo selection using Preimplantation Genetic Testing for Aneuploidy is seen as a promising method to enhance live birth (LB) rates. The impact of a history of RPL on the LB rate following euploid frozen embryo transfer remains a subject of contentious debate. Study design, size, duration This retrospective study was conducted in a tertiary IVF centre between 2017 and 2025 and included a total of 775 cycles who underwent an ovarian stimulation in a standard ovarian stimulation protocol and at least one frozen embryo transfer, performed either as Hormonal-Replacement-Cycle (HRT) or Natural-cycle (NC). Participants/materials, setting, methods Women undergoing euploid frozen embryo transfer (FET) were included. The RPL cohort had a completed work-up (lupus anticoagulant [LA], antinuclear antibodies [ANA], thyroid-stimulating hormone [TSH]) and was classified as RPL-normal (all three normal) or RPL-abnormal (≥1 abnormal). Controls had ≥1 prior pregnancy/live birth and no miscarriage history. Embryo euploidy was confirmed by next-generation sequencing. The primary outcome was LB per transfer. Multivariable logistic regression adjusted for age, BMI, and transfer of ≥ 1 Top/Good euploid embryo. Main results and the role of chance A total of 775 euploid transfer cycles were analysed (Control n = 579; RPL n = 196), including RPL-normal work-up (n = 101) and RPL-abnormal work-up (n = 95). Age showed a small but statistically significant difference across groups (median 35 [31–38] in controls vs 34 [30–37] and 34 [29–37] in RPL-normal and RPL-abnormal; p = 0.007). AMH was comparable (2.2 [1.1–3.7] vs 2.4 [1.2–3.8] vs 2.4 [1.2–4.5]; p = 0.171), while BMI was slightly higher in RPL (26.7 [23.6–29.9] vs 27.8 [24.2–31.2] vs 27.7 [24.5–30.8]; p = 0.045). Gravidity was higher in RPL women as expected (2 [1–3] vs 4 [3–6] vs 4 [3–6.5]; p < 0.001). Cycle characteristics differed modestly, with lower SET rates and more HRT use in RPL, whereas embryo quality per transfer was similar (∼84–86% had ≥1 Top/Good euploid embryo). Crude LB-rates showed a gradient: 50.4% (Control), 36.7% (RPL-normal), and 27.2% (RPL-abnormal) (p < 0.001). In adjusted models, both RPL subgroups had lower odds of LB versus controls (RPL-normal aOR 0.58, 95% CI 0.37–0.89, p = 0.015; RPL-abnormal aOR 0.36, 0.22–0.59, p < 0.001). Having ≥1 Top/Good euploid embryo increasedLB odds (aOR 2.34, 1.53–3.65, p < 0.001). Within RPL, abnormal vs normal work-up trended lower (aOR 0.63, 0.34–1.16, p = 0.140) but not significant. Limitations, reasons for caution Limitations include the retrospective design, potential selection bias, and modest sample size. Heterogeneity among RPL patients, variability in laboratory-testing, the potential inability of PGT-A platforms to detect small aberrations and exclusion of immunological evaluations (e.g. KIR/HLA) may confound results and restrict applicability and interpretation of causal conclusions. Wider implications of the findings Although aneuploidy is potentially excluded in assumed euploid transfers as a cause of pregnancy loss, this approach does not mitigate the diminished likelihood of LB in women with RPL. Consequently, subsequent studies with improved PGT plattforms should assess other parental factors contributing to RPL Trial registration number No

Zitieren

APA

Blagojevic, T., Didar, H., Lawrenz, B., Selim, S., Elkhatib, I., & Fatemi, H. (2026). L26/O-275 Beyond euploidy: euploid frozen embryo transfer does not improve live birth rates in women with recurrent pregnancy loss. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.273

Vancouver

Blagojevic T, Didar H, Lawrenz B, Selim S, Elkhatib I, Fatemi H. L26/O-275 Beyond euploidy: euploid frozen embryo transfer does not improve live birth rates in women with recurrent pregnancy loss. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.273

BibTeX
@article{Blagojevic2026,
  author = {Blagojevic, T. and Didar, H. and Lawrenz, B. and Selim, S. and Elkhatib, I. and Fatemi, H.},
  title = {L26/O-275 Beyond euploidy: euploid frozen embryo transfer does not improve live birth rates in women with recurrent pregnancy loss},
  journal = {Human Reproduction},
  year = {2026},
  volume = {41},
  number = {Supplement_1},
  doi = {10.1093/humrep/deag083.273}
}
Kostenlos starten →